Literature DB >> 16368960

Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.

Benedito A Carneiro1, Jun Fujii, Gerly A C Brito, Cirle Alcantara, Reinaldo B Oriá, Aldo A M Lima, Tom Obrig, Richard L Guerrant.   

Abstract

Clostridium difficile is the leading cause of nosocomial bacterial diarrhea. Glutamine and its stable and highly soluble derivative alanyl-glutamine, have been beneficial in models of intestinal injury. In this study, we extend our work on the mechanisms of Clostridium difficile toxin A (TxA)-induced apoptosis in human intestinal epithelial T84 cells and evaluate the effects of glutamine and alanyl-glutamine on TxA-induced apoptosis in vitro and disruption of ileal mucosa in vivo. T84 cells were incubated with TxA (100 ng/ml) in medium with or without glutamine or alanyl-glutamine (3 to 100 mM). Apoptosis was evaluated by DNA fragmentation in vitro and the terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling method in vivo. Caspase and Bid involvement were investigated by Western blotting. Ligated rabbit ileal loops were used for the evaluation of intestinal secretion, mucosal disruption, and apoptosis. TxA induced caspases 6, 8, and 9 prior to caspase 3 activation in T84 cells and induced Bid cleavage by a caspase-independent mechanism. Glutamine or alanyl-glutamine significantly reduced TxA-induced apoptosis of T84 cells by 47% and inhibited activation of caspase 8. Both glutamine and alanyl-glutamine reduced TxA-induced ileal mucosal disruption and secretion. Altogether, we further delineated the apoptosis-signaling cascade induced by TxA in T84 cells and demonstrated the protective effects of glutamine and alanyl-glutamine. Glutamine and alanyl-glutamine inhibited the apoptosis of T84 cells by preventing caspase 8 activation and reduced TxA-induced intestinal secretion and disruption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368960      PMCID: PMC1346681          DOI: 10.1128/IAI.74.1.81-87.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway.

Authors:  M J Pinkoski; N J Waterhouse; J A Heibein; B B Wolf; T Kuwana; J C Goldstein; D D Newmeyer; R C Bleackley; D R Green
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile.

Authors:  A P Limaye; D K Turgeon; B T Cookson; T R Fritsche
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 3.  Glutamine and heat shock protein expression.

Authors:  Paul E Wischmeyer
Journal:  Nutrition       Date:  2002-03       Impact factor: 4.008

4.  Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes.

Authors:  K S Sellins; J J Cohen
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

5.  Uptake and metabolism of plasma glutamine by the small intestine.

Authors:  H G Windmueller; A E Spaeth
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.

Authors:  T R Ziegler; L S Young; K Benfell; M Scheltinga; K Hortos; R Bye; F D Morrow; D O Jacobs; R J Smith; J H Antin
Journal:  Ann Intern Med       Date:  1992-05-15       Impact factor: 25.391

8.  Effects of an alanyl-glutamine-based oral rehydration and nutrition therapy solution on electrolyte and water absorption in a rat model of secretory diarrhea induced by cholera toxin.

Authors:  Aldo A M Lima; Graça H P Carvalho; Aline A Figueiredo; Angela R Gifoni; Alberto M Soares; Eduardo A T Silva; Richard L Guerrant
Journal:  Nutrition       Date:  2002-06       Impact factor: 4.008

9.  Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells.

Authors:  Mary E Evans; Dean P Jones; Thomas R Ziegler
Journal:  J Nutr       Date:  2003-10       Impact factor: 4.798

10.  Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors:  V Bitko; S Barik
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  37 in total

1.  Utilizing case reports to build awareness of rare complications in critical care.

Authors:  Rachel R Walden; Rebecca N Jerome; Richard S Miller
Journal:  J Med Libr Assoc       Date:  2007-01

2.  Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.

Authors:  Nuntra Suwantarat; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

3.  Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.

Authors:  Johannes Huelsenbeck; Stefanie Dreger; Ralf Gerhard; Holger Barth; Ingo Just; Harald Genth
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

4.  Ileal smooth muscle motility depression on rabbit induced by toxin A from Clostridium difficile.

Authors:  Crystianne Calado Lima; João Luis Carvalho-de-Souza; Aldo Angelo Moreira Lima; José Henrique Leal-Cardoso
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

5.  Role of retinol in protecting epithelial cell damage induced by Clostridium difficile toxin A.

Authors:  Andressa A F L Maciel; Reinaldo B Oriá; Manuel B Braga-Neto; Andréa B Braga; Eunice B Carvalho; Herene B M Lucena; Gerly A C Brito; Richard L Guerrant; Aldo A M Lima
Journal:  Toxicon       Date:  2007-07-31       Impact factor: 3.033

6.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; D Borden Lacy
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

7.  Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.

Authors:  Cirle A Warren; Yuesheng Li; Gina M Calabrese; Rosemayre S Freire; Snjezana Zaja-Milatovic; Edward van Opstal; Robert A Figler; Joel Linden; Richard L Guerrant
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

8.  Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.

Authors:  Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

9.  Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Authors:  Raphael S Rodrigues; Renato A C Oliveira; Yuesheng Li; Snjezana Zaja-Milatovic; Lourrany B Costa; Manuel B Braga Neto; Glynis L Kolling; Aldo A Lima; Richard L Guerrant; Cirle Alcantara Warren
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

10.  Protective effects of alanyl-glutamine supplementation against nelfinavir-induced epithelial impairment in IEC-6 cells and in mouse intestinal mucosa.

Authors:  Manuel B Braga-Neto; Bruna M C Oliveira; Raphael S Rodrigues; Francisco J Noronha; Renata F Leitao; Gerly A C Brito; Aldo A Lima; Richard L Guerrant; Cirle A Warren
Journal:  Cancer Biol Ther       Date:  2012-09-17       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.